Risk Factor Analysis for Bridge to Transplantation With the CardioWest Total Artificial Heart

Jack G. Copeland, Richard G. Smith, Raj K. Bose, Pei H. Tsau, Paul E. Nolan, Marvin J Slepian

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Safety and efficacy studies of various mechanical circulatory support devices are important, but may not be strictly comparable. Lacking prospective randomized studies for different devices, we believe that comparison of risk factor analyses may give the surgeon a tool more powerful than current studies for matching a patient with an appropriate device. In this paper, we report risk factor profiles for bridge to transplantation with the CardioWest total artificial heart and summarize reports for other devices. Methods: A multiinstitutional risk factor analysis of the CardioWest total artificial heart, as a bridge to transplantation in 81 patients, was conducted. Univariate analyses were performed on 43 preimplantation prognostic factors. From this group, eight factors were chosen for multivariate analysis. Our results were compared with all recent risk factor analyses for other devices. Results: Independent predictors for death at three intervals by multivariate analysis were as follows: "implant to transplant": history of smoking (odds ratio, 34); "implant to 30 days after transplant": history of smoking (odds ratio, 10.00), prothrombin time greater than 16 seconds (odds ratio, 4.76); and "implant to 1 year after transplant": prothrombin time greater than 16 seconds (odds ratio, 3.85). The major difference between this experience and multiple reported experiences with left ventricular assist devices is that for left ventricular assist devices, but not for the temporary CardioWest total artificial heart, right heart failure, high central venous pressure, and being on a ventilator (with or without sepsis) were independent predictors of mortality. Conclusions: Risk factors for bridge to transplantation with the CardioWest total artificial heart are different from those reported for left ventricular assist devices. Recognition of these risk factor differences may facilitate appropriate device selection.

Original languageEnglish (US)
Pages (from-to)1639-1644
Number of pages6
JournalAnnals of Thoracic Surgery
Volume85
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Artificial Heart
Statistical Factor Analysis
Transplantation
Equipment and Supplies
Heart-Assist Devices
Odds Ratio
Prothrombin Time
Transplants
Multivariate Analysis
Smoking
Central Venous Pressure
Mechanical Ventilators
Sepsis
Heart Failure
Prospective Studies
Safety
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Risk Factor Analysis for Bridge to Transplantation With the CardioWest Total Artificial Heart. / Copeland, Jack G.; Smith, Richard G.; Bose, Raj K.; Tsau, Pei H.; Nolan, Paul E.; Slepian, Marvin J.

In: Annals of Thoracic Surgery, Vol. 85, No. 5, 05.2008, p. 1639-1644.

Research output: Contribution to journalArticle

Copeland, Jack G. ; Smith, Richard G. ; Bose, Raj K. ; Tsau, Pei H. ; Nolan, Paul E. ; Slepian, Marvin J. / Risk Factor Analysis for Bridge to Transplantation With the CardioWest Total Artificial Heart. In: Annals of Thoracic Surgery. 2008 ; Vol. 85, No. 5. pp. 1639-1644.
@article{5a36bf01461f4fbbb39acbeaefa936b2,
title = "Risk Factor Analysis for Bridge to Transplantation With the CardioWest Total Artificial Heart",
abstract = "Background: Safety and efficacy studies of various mechanical circulatory support devices are important, but may not be strictly comparable. Lacking prospective randomized studies for different devices, we believe that comparison of risk factor analyses may give the surgeon a tool more powerful than current studies for matching a patient with an appropriate device. In this paper, we report risk factor profiles for bridge to transplantation with the CardioWest total artificial heart and summarize reports for other devices. Methods: A multiinstitutional risk factor analysis of the CardioWest total artificial heart, as a bridge to transplantation in 81 patients, was conducted. Univariate analyses were performed on 43 preimplantation prognostic factors. From this group, eight factors were chosen for multivariate analysis. Our results were compared with all recent risk factor analyses for other devices. Results: Independent predictors for death at three intervals by multivariate analysis were as follows: {"}implant to transplant{"}: history of smoking (odds ratio, 34); {"}implant to 30 days after transplant{"}: history of smoking (odds ratio, 10.00), prothrombin time greater than 16 seconds (odds ratio, 4.76); and {"}implant to 1 year after transplant{"}: prothrombin time greater than 16 seconds (odds ratio, 3.85). The major difference between this experience and multiple reported experiences with left ventricular assist devices is that for left ventricular assist devices, but not for the temporary CardioWest total artificial heart, right heart failure, high central venous pressure, and being on a ventilator (with or without sepsis) were independent predictors of mortality. Conclusions: Risk factors for bridge to transplantation with the CardioWest total artificial heart are different from those reported for left ventricular assist devices. Recognition of these risk factor differences may facilitate appropriate device selection.",
author = "Copeland, {Jack G.} and Smith, {Richard G.} and Bose, {Raj K.} and Tsau, {Pei H.} and Nolan, {Paul E.} and Slepian, {Marvin J}",
year = "2008",
month = "5",
doi = "10.1016/j.athoracsur.2008.01.052",
language = "English (US)",
volume = "85",
pages = "1639--1644",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Risk Factor Analysis for Bridge to Transplantation With the CardioWest Total Artificial Heart

AU - Copeland, Jack G.

AU - Smith, Richard G.

AU - Bose, Raj K.

AU - Tsau, Pei H.

AU - Nolan, Paul E.

AU - Slepian, Marvin J

PY - 2008/5

Y1 - 2008/5

N2 - Background: Safety and efficacy studies of various mechanical circulatory support devices are important, but may not be strictly comparable. Lacking prospective randomized studies for different devices, we believe that comparison of risk factor analyses may give the surgeon a tool more powerful than current studies for matching a patient with an appropriate device. In this paper, we report risk factor profiles for bridge to transplantation with the CardioWest total artificial heart and summarize reports for other devices. Methods: A multiinstitutional risk factor analysis of the CardioWest total artificial heart, as a bridge to transplantation in 81 patients, was conducted. Univariate analyses were performed on 43 preimplantation prognostic factors. From this group, eight factors were chosen for multivariate analysis. Our results were compared with all recent risk factor analyses for other devices. Results: Independent predictors for death at three intervals by multivariate analysis were as follows: "implant to transplant": history of smoking (odds ratio, 34); "implant to 30 days after transplant": history of smoking (odds ratio, 10.00), prothrombin time greater than 16 seconds (odds ratio, 4.76); and "implant to 1 year after transplant": prothrombin time greater than 16 seconds (odds ratio, 3.85). The major difference between this experience and multiple reported experiences with left ventricular assist devices is that for left ventricular assist devices, but not for the temporary CardioWest total artificial heart, right heart failure, high central venous pressure, and being on a ventilator (with or without sepsis) were independent predictors of mortality. Conclusions: Risk factors for bridge to transplantation with the CardioWest total artificial heart are different from those reported for left ventricular assist devices. Recognition of these risk factor differences may facilitate appropriate device selection.

AB - Background: Safety and efficacy studies of various mechanical circulatory support devices are important, but may not be strictly comparable. Lacking prospective randomized studies for different devices, we believe that comparison of risk factor analyses may give the surgeon a tool more powerful than current studies for matching a patient with an appropriate device. In this paper, we report risk factor profiles for bridge to transplantation with the CardioWest total artificial heart and summarize reports for other devices. Methods: A multiinstitutional risk factor analysis of the CardioWest total artificial heart, as a bridge to transplantation in 81 patients, was conducted. Univariate analyses were performed on 43 preimplantation prognostic factors. From this group, eight factors were chosen for multivariate analysis. Our results were compared with all recent risk factor analyses for other devices. Results: Independent predictors for death at three intervals by multivariate analysis were as follows: "implant to transplant": history of smoking (odds ratio, 34); "implant to 30 days after transplant": history of smoking (odds ratio, 10.00), prothrombin time greater than 16 seconds (odds ratio, 4.76); and "implant to 1 year after transplant": prothrombin time greater than 16 seconds (odds ratio, 3.85). The major difference between this experience and multiple reported experiences with left ventricular assist devices is that for left ventricular assist devices, but not for the temporary CardioWest total artificial heart, right heart failure, high central venous pressure, and being on a ventilator (with or without sepsis) were independent predictors of mortality. Conclusions: Risk factors for bridge to transplantation with the CardioWest total artificial heart are different from those reported for left ventricular assist devices. Recognition of these risk factor differences may facilitate appropriate device selection.

UR - http://www.scopus.com/inward/record.url?scp=42949088907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949088907&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2008.01.052

DO - 10.1016/j.athoracsur.2008.01.052

M3 - Article

C2 - 18442554

AN - SCOPUS:42949088907

VL - 85

SP - 1639

EP - 1644

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -